GILEAD SCIENCES, INC. Interest Receivable, Current
GILEAD SCIENCES, INC. (GILD) had Interest Receivable, Current of $9.00 million as of 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Notes › and Others
us-gaap:InterestReceivableCurrent · last filed 2021-05-06
- 2021-03-31: Interest Receivable, Current $9.00M.
- 2020-12-31: Interest Receivable, Current $9.00M.
- 2020-09-30: Interest Receivable, Current $49.00M.
- 2020-06-30: Interest Receivable, Current $56.00M.
| Period end | Interest Receivable, Current |
|---|---|
| 2021-03-31 | $9.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $9.00M 10-Q · filed 2021-05-06 |
| 2020-09-30 | $49.00M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $56.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $60.00M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $37.00M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |